Osaic Holdings
BOLT icon

Osaic Holdings’s Bolt Biotherapeutics BOLT Stock Holding History

Osaic Holdings’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-118
Closed -$1.27K – 7464
2024
Q4 		$1.27K Sell
118
-750
-86% -$9.07K ﹤0.01% 6758
2024
Q3 		$11.3K Buy
868
+118
+16% +$1.63K ﹤0.01% 5743
2024
Q2 		$11.3K Hold
750
– – ﹤0.01% 5706
2024
Q1 		$21K Buy
750
+551
+277% +$12.8K ﹤0.01% 5337
2023
Q4 		$4.46K Buy
+199
New +$3.87K ﹤0.01% 6219
2023
Q1 		– Sell
-5
Closed – – 7500
2022
Q4 		$0 Sell
5
-19
-79% -$521 ﹤0.01% 7181
2022
Q3 		$1K Sell
24
-3
-11% -$124 ﹤0.01% 6946
2022
Q2 		$1K Buy
27
+22
+440% +$854 ﹤0.01% 7035
2022
Q1 		$0 Sell
5
-98
-95% -$6.6K ﹤0.01% 7248
2021
Q4 		$9K Buy
103
+71
+222% +$13.5K ﹤0.01% 6316
2021
Q3 		$8K Buy
32
+19
+146% +$5.37K ﹤0.01% 6316
2021
Q2 		$4K Buy
+13
New +$5.28K ﹤0.01% 6459

Other funds holding BOLT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings's BOLT Position: Q1 2025 in Review

Osaic Holdings sold out of Bolt Biotherapeutics (BOLT) in Q1 2025, closing a stake of 118 shares — an estimated $1.27K sold.

Osaic Holdings first reported a position in BOLT in Q2 2021 and held it in 12 quarters. The position peaked at $21K in Q1 2024. 29 funds tracked by Wall St. Rank hold BOLT as of Q1 2025.

  • Osaic Holdings reported no remaining Bolt Biotherapeutics position as of Q1 2025 after selling out during the quarter.
  • Osaic Holdings sold 118 Bolt Biotherapeutics shares in Q1 2025, an estimated $1.27K.
  • Osaic Holdings first reported a position in Bolt Biotherapeutics in Q2 2021 and held it in 12 quarters.
  • Osaic Holdings's Bolt Biotherapeutics position peaked at $21K in Q1 2024.
  • 29 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.